Chalmers-Redman RM - Search Results

1

Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells.

Tatton WG, Chalmers-Redman RM, Ju WJ, Mammen M, Carlile GW, Pong AW, Tatton NA. Tatton WG, et al. Among authors: chalmers redman rm. J Pharmacol Exp Ther. 2002 May;301(2):753-64. doi: 10.1124/jpet.301.2.753. J Pharmacol Exp Ther. 2002. PMID: 11961082

2

Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B.

Tatton W, Chalmers-Redman R, Tatton N. Tatton W, et al. J Neural Transm (Vienna). 2003 May;110(5):509-15. doi: 10.1007/s00702-002-0827-z. J Neural Transm (Vienna). 2003. PMID: 12721812 Review.

3

Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer.

Carlile GW, Chalmers-Redman RM, Tatton NA, Pong A, Borden KE, Tatton WG. Carlile GW, et al. Among authors: chalmers redman rm. Mol Pharmacol. 2000 Jan;57(1):2-12. Mol Pharmacol. 2000. PMID: 10617673

4

Apoptosis in Parkinson's disease: signals for neuronal degradation.

Tatton WG, Chalmers-Redman R, Brown D, Tatton N. Tatton WG, et al. Ann Neurol. 2003;53 Suppl 3:S61-70; discussion S70-2. doi: 10.1002/ana.10489. Ann Neurol. 2003. PMID: 12666099 Review.

5

Ovarian steroids reduce apoptosis induced by trophic insufficiency in nerve growth factor-differentiated PC12 cells and axotomized rat facial motoneurons.

MacLusky NJ, Chalmers-Redman R, Kay G, Ju W, Nethrapalli IS, Tatton WG. MacLusky NJ, et al. Neuroscience. 2003;118(3):741-54. doi: 10.1016/s0306-4522(02)00940-5. Neuroscience. 2003. PMID: 12710981

6

Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenyl.

Wadia JS, Chalmers-Redman RM, Ju WJ, Carlile GW, Phillips JL, Fraser AD, Tatton WG. Wadia JS, et al. J Neurosci. 1998 Feb 1;18(3):932-47. doi: 10.1523/JNEUROSCI.18-03-00932.1998. J Neurosci. 1998. PMID: 9437015 Free PMC article.

7

Mitochondria in neurodegenerative apoptosis: an opportunity for therapy?

Tatton WG, Chalmers-Redman RM. Tatton WG, et al. Ann Neurol. 1998 Sep;44(3 Suppl 1):S134-41. doi: 10.1002/ana.410440720. Ann Neurol. 1998. PMID: 9749585 Review.

8

Glucose protection from MPP+-induced apoptosis depends on mitochondrial membrane potential and ATP synthase.

Chalmers-Redman RM, Fraser AD, Carlile GW, Pong A, Tatton WG. Chalmers-Redman RM, et al. Biochem Biophys Res Commun. 1999 Apr 13;257(2):440-7. doi: 10.1006/bbrc.1999.0487. Biochem Biophys Res Commun. 1999. PMID: 10198232

9

Nuclear translocation of GAPDH-GFP fusion protein during apoptosis.

Shashidharan P, Chalmers-Redman RM, Carlile GW, Rodic V, Gurvich N, Yuen T, Tatton WG, Sealfon SC. Shashidharan P, et al. Among authors: chalmers redman rm. Neuroreport. 1999 Apr 6;10(5):1149-53. doi: 10.1097/00001756-199904060-00045. Neuroreport. 1999. PMID: 10321500

10

Reduced mitochondrial membrane potential and altered responsiveness of a mitochondrial membrane megachannel in p53-induced senescence.

Sugrue MM, Wang Y, Rideout HJ, Chalmers-Redman RM, Tatton WG. Sugrue MM, et al. Among authors: chalmers redman rm. Biochem Biophys Res Commun. 1999 Jul 22;261(1):123-30. doi: 10.1006/bbrc.1999.0984. Biochem Biophys Res Commun. 1999. PMID: 10405334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters